Bone Biologics Corporatio... (BBLG)
undefined
undefined%
At close: undefined
1.10
-0.24%
After-hours Dec 13, 2024, 07:55 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08
Revenue - - - - - - - - - - - - - - - -
Cost of Revenue - - - - 50.00 96.00 96.00 700.00 4.45K 877.78K - - 3.00K 3.00K 3.00K -
Gross Profit - - - - -50 -96 -96 -700 -4.45K -877.78K - - -3.00K -3.00K -3.00K -
Operating Income -9.43M -3.67M -1.10M -825.01K -2.45M -2.79M -2.63M -17.85M -12.00M -3.01M -671.99K -435.66 -3.00K -3.00K -3.00K -13.34K
Interest Income 1.87K 731.71 805.11 998.08 - - - - - - - - - - - -
Pretax Income -8.95M -1.48M -1.61M -1.82M -3.42M -4.43M -7.05M -21.03M -13.87M -4.42M -1.08M -714.76 - - - -13.34K
Net Income -8.95M 695.93K -1.61M -1.82M -3.42M -4.43M -7.05M -21.03M -13.88M -4.42M -1.08M -715.57 - - - -13.34K
Selling & General & Admin 2.52M 2.09M 1.02M 484.34K 1.35M 2.69M 3.82M 6.25M 8.33M 1.51M 483.75K 180.09 - - - -
Research & Development 6.91M 1.58M 82.04K 340.67K 1.10M 104.49K -1.19M 11.60M 3.67M 623.52K 188.24K 255.57 - - - -
Other Expenses - - - - - 104.49K 2.63M - - -9.62K - - - - - -13.34K
Operating Expenses 9.43M 3.67M 1.10M 825.01K 2.45M 2.79M 2.63M 17.85M 12.00M 3.01M 671.99K 435.66 - - - -13.34K
Interest Expense - - 805.11K 998.08K 975.77K 1.23M 4.42M 3.17M 1.87M 1.40M - - - - - -
Selling & Marketing Expenses - - - - - - - - - - - - - - - -
Cost & Expenses 9.43M 3.67M 1.10M 825.01K 2.45M 2.79M 2.63M 17.85M 12.00M 3.01M 671.99K 435.66 3.00K 3.00K 3.00K -13.34K
Income Tax - -2.18M 1.60K 1.60K 1.60K 1.73K 1.60K 2.24K 8.84K 1.60K 800.00 0.80 - - - -
Shares Outstanding (Basic) 263.14K 47.00K 43.00K 51.00K 51.00K - - - - - - 14.00 5.00M 5.00M 5.00M 5.00M
Shares Outstanding (Diluted) 263.14K 47.66K 43.13K 51.14K 51.14K - - - - - - 14.57 5.00M 5.00M 5.00M 5.00M
EPS (Basic) -34.01 -31.15 -37.35 -35.68 -66.97 - - - - - - -49.11 - - - -0.00
EPS (Diluted) -34.01 -31.15 -37.35 -35.68 -66.97 - - - - - - -49.11 - - - -0.00
EBITDA 479.57K - - -825.01K -2.45M -2.79M -2.63M -20.41M -11.99M -3.02M - -5.23K -4.52K -3.00K -3.00K -13.34K
Depreciation & Amortization 9.43M 3.67M 1.10M 50.00 50.00 96.00 96.00 700.00 4.45K 280.00 671.99K 435.66 - - - -